Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Immunohematology Market Forecast 2028 By End Use (Hospitals, Diagnostic Laboratories, Blood Banks), By Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-Magnetized Technology (EMT)), By Product (Analyzers & Systems, Reagents), Research Report, Country Outlook (Japan, China, India), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: November 2022   |   Report ID: GR1301   |   Delivery: PDF  Request Free Sample

    Asia Pacific Immunohematology Market size crossed USD 680 million in 2021 and is projected to showcase around 5% growth rate between 2022 and 2028.

    Asia Pacific Immunohematology Market

    Get more details on this report - Request Free Sample PDF

    The rising number diabetes cases and a growing elderly population, who are more sensitive to cardiovascular ailments, will impact the market trends. It is projected that by 2060, more than 1.2 billion Asians will be 65 or older in age. This will lead to age-related chronic diseases and weak immunity among this population.

    As China and India are claimed to be among the nations with the most diabetic people, the countries are expected to highly contribute to the industry. By 2025, there will likely be 70 million people in India who have diabetes, and there will likely be 80 million by the end of 2030. Additionally, diabetes is now one of the region’s main contributors towards both cardiovascular disease and blindness.

    Asia Pacific Market, By Product

    The reagents segment is expected to reach USD 620 million by 2028, due to rise in number of blood-related diseases in the region. There is increased use of reagents in healthcare facilities, including hospitals and clinics, for more frequent blood testing.

    Asia Pacific Immunohematology Market, By End-users

    The hospitals segment is expected to show tremendous growth during the forecast timeline, owing to the increased utilization of immunohematology products such as analyzers and reagents for blood testing. Hospitals can offer better services and many medical professionals to provide patient care. Also, the growing prevalence of blood disorders coupled with the rising diabetes population in emerging economies will further influence the consumer preference for treatment at hospitals.

    Asia Pacific Market, By technology

    The gel cards technology segment will witness 30% CAGR through 2028. As gel cards provide multiple advantages over conventional saline tubes, they have become a common choice. Factors contributing to product uptake are that they need less time to use, are more sensitive, completely recordable, and are more stable for extended periods of time. Finding relevant antibodies is easier and more efficient using gel card technology.

    Competitive Industry Landscape

    Major players involved in the Asia Pacific immunohematology market include Abbott, Becton Dickinson, F. Hoffmann-La Roche Ltd., Hologic, and Bio-Rad Laboratories. Most of these organizations invest heavily toward portfolio expansion as well as to boost their production capacity.

    Frequently Asked Question(FAQ) :

    What is the value of Asia Pacific immunohematology market?
    The market size for immunohematology in APAC was exceeded USD 680 million in 2021 and is expected to register a CAGR of more than 5% through the forecast years 2022 – 2028.
    Why is the demand for reagents growing in APAC immunohematology sector?
    The market share for immunohematology in Asia Pacific from the reagents segment is expected to cross USD 620 million by 2028 with a consistent rise in blood-related diseases across the region.
    Which companies provide immunohematology products in Asia Pacific?
    Some of the major companies in APAC industry include Abbott, Becton Dickinson, F. Hoffmann-La Roche Ltd., Hologic, and Bio-Rad Laboratories, among a few others.
    How has COVID-19 affected APAC immunohematology industry?
    The COVID-19 pandemic disrupted medical services across healthcare facilities, as blood transfusion and other related activities were majorly affected due to the fear of virus transmission.

    Get this research report on Asia Pacific Immunohematology Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]